DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170121

Spectrum of opportunistic infections with correlation to CD4 counts in newly diagnosed HIV seropositive cases

Ajay Kumar Sarvepalli, Prakash Kalakappa Dharana

Abstract


Background: A rise in HIV/AIDS is observed in resource poor countries like India despite successful implementation of control programmes. Most of these deaths recorded in cases of AIDS are because of opportunistic infections [OI] and other malignancies. The reason may be attributed to the effective destruction or decrease in CD4 cells which play a pivotal role in immune system. OI cause substantial morbidity and hospitalization, economical loss to the society and shorten the survival time of HIV patient. The objective of this study was to evaluate the different type of infections and identify the frequent pathogens affecting the HIV patients who are attending a tertiary care hospital in India. The clinical profile of these patients was studied and proportion of CD4 counts with respect to their type of infection and pathogen is also evaluated.

Methods: A prospective cross sectional study was conducted for one year period. Clinical samples were collected from all the newly diagnosed cases of HIV and performed various staining techniques and cultured on appropriate culture media.  All the isolates were identified as per standard guidelines. Serological evaluation for IgM antibodies for toxoplasma was done by ELISA. CD4 counts were estimated by FACS.

Results: Tuberculosis was the commonest (67%) OI in HIV cases, followed by candidiasis (61.5%), respiratory tract infections (50%), gastro intestinal tract infections (44%) and meningitis (38%) in our study. The mean CD4 cell counts in the study was 267.11cells/µl. The commonest fungal pathogen was C.albicans and Cryptosporidium parvum the parasitic pathogen. The mean CD4 cell counts were lesser in parasitic infections when compared to bacterial and fungal infections. Six cases of P.jiroveci pneumonia were identified in our study. Mortality was recorded among the HIV cases with CD4 cell counts <50 cells/ µl.

Conclusions: Early diagnosis and prompt treatment of OIs contributes to increased life expectancy among infected patients, delaying the progression to AIDS. This study helps the clinicians in proper guidance to come up with right diagnosis and early response to manage the patients in resource poor countries like India.


Keywords


AIDS, CD4 counts, HIV, Opportunistic infections, Tuberculosis

Full Text:

PDF

References


Joint United Nations Programme on HIV/AIDS (UNAIDS). The gap report 2014. Available at http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf. Accessed on 21 November 2015.

Palella FJ, Baker RK, Moorman AC. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006.

Moore RD, Chaisson RE. Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med. 1996;124:633-42.

Smit C, Geskus R, Walker S. Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS. 2006;20:741-5.

National AIDS Control Organization. Guidelines on HIV Testing. NACO; 2007.

Center for Disease Control (1992). Revised Classification system for HIV infection and expanded Surveillance for case definition for AIDS among adolescents and adults. Morbid. Mortal. Wkly. Rec., 41, RR-41; 1993.

National AIDS Control Organization. National Guidelines for the Enumeration of CD4’ T-Lymphocytes with Single Platform Technology for Initiation and Monitoring of Art in HIV Infected Individuals. NACO; 2007.

Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 1992;15:211-22.

Singh A, Bairy I, Shivananda PG. Spectrum of Oppurtunistic infections in AIDS cases. Indian J Med Science. 2003;57(1):16-21.

Sharma SK, Khadiravan T, Banga A. Spectrum of clinical disease in a series of 135 hospitalized HIV-infected patients from North India. BMC infect Dis. 2004;4:52.

Chakravarty J, Mehtha H, Parekh A. Study on Clinico- epidemiological profile of HIV patients in eastern India. JAPI. 2006;54;854-7.

National AIDS control Programme. Ministry of Health and Family Welfare, Govt of India: Country scenario: An Update. New Delhi. India; 2006.

Global tuberculosis report. 20th edition. World Health Organization; 2015.

Merchant RH, Oswal JS, Bhagwat RV, Karkare J. Clinical profile of HIV infection. Indian Pediatr. 2001;38:239-46.

Pol RR, Shepur TA, Ratageri VH. Clinico-laboratory profile of pediatric HIV in Karnataka. Indian J Pediatr. 2007;74:1071-5.

Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003;36:79-85.

Shahapur PR, Bidri RC. Recent trends in the spectrum of opportunistic infections in human immunodeficiency virus infected individuals on antiretroviral therapy in South India. J Nat Sci Biol Med. 2014;5:392-6.

Srirangaraj S, Venkatesha D. Opportunistic infectionsin relation to antiretroviral status among AIDS patients fromsouth India. Indian J Med Microbiol. 2011;29(4):395-400.

Russian DA, Kovacs JA. Pneumocystis carinii in Africa: an emerging pathogen? Lancet. 1995;346:1242-3.

Kaur R, Dhakad MS, Goyal R, Bhalla P, Dewan R. Spectrum of opportunistic fungal infections in HIV/AIDS patients in tertiary care hospital in India. Can J Infect Dis Med Microbiol. 2016:e2373424.

Bharathi M, Rani AU. Pathogenic fungal isolates in sputum of HIV positive patients. Journal of AIDS and HIV Research. 2011;3(6)107-13.

Dabla V, Gupta AK, Singh I. Spectrum of opportunistic infections among HIV seropositive patients in Delhi region-a study by Delhi state AIDS control society. J Med Disord. 2015;3:1.

Sadraei J, Rizvi MA, Baveja UK. Diarrhea, CD4+ cell counts and opportunistic protozoa in Indian HIV-infected patients. Parasitol Res. 2005;97:270-3.

Ramana KV, Mohanty SK. Opportunistic intestinal parasites and TCD4+ cell counts in human immunodeficiency virus seropositive patients. J Med Microbiol. 2009;58:1664-6.